|
Top : For Professionals Only : Page 3
CF Resources: For Professionals Only
Categories:
Links:
- Orphan Drug Designation for Aztreonam For Inhalation Therapy (2002)
- Corus Pharma announced that Corus 1020
(aztreonam) has been granted orphan drug designation by the U.S. Food and Drug
Administration (FDA) for inhalation therapy for control of gram-negative
bacteria in the respiratory tract of patients with cystic fibrosis. Corus 1020 is an antibiotic that has a broad spectrum of activity against
gram-negative bacteria. Inhaled antibiotics effectively treat gram-negative
infections in patients with cystic fibrosis because of the higher local
concentrations of drug at the site of infection.
(Added: 23-Oct-2002 Hits: 11 Rating: 0 ) Rate It
- P. cystic fibrosis: past, present, future
- Most patients with cystic fibrosis (CF) suffer from recurrent and chronic endobronchial P aeruginosa infections. The accumulated knowledge shows that it is possible to prevent or delay the onset of these chronic infections in most CF patients by eliminating cross-infection and by early aggressive antibiotic treatment of intermittent colonization.
(1998)
(Added: 18-Sep-2002 Hits: 14 Rating: 0 ) Rate It
- Pain research
- Research opportunities, abstracts describing recent findings
(Added: 1-Dec-2002 Hits: 36 Rating: 0 ) Rate It
- Pediatric Pain Listserv
- This listserv is an international Internet forum for informal discussion of any topic related to pain in children. The listserv is open to professionals and interested persons of the public. Topics discussed include: clincial problems and questions, research issues, announcement of pain-related meetings, book reviews, practical aspects of children's pain assessment, measurement, and management.
(Added: 1-Dec-2002 Hits: 13 Rating: 0 ) Rate It
- Pharmaceutical Research and Manufacturers' Assistance Program
- The mission of the PhRMA Foundation is to support young scientists in disciplines important to the pharmaceutical industry by awarding them competitive research fellowships and grants at a critical decision point at the outset of their careers
(Added: 16-Sep-2002 Hits: 10 Rating: 0 ) Rate It
- Press Release
- Oxford GlycoSciences and Cystic Fibrosis Foundation Therapeutics Inc. Launch a Major Proteomics Initiative to Advance Management of CF
(July 12, 2002)
(Added: 14-Aug-2002 Hits: 23 Rating: 0 ) Rate It
- Prilosec Delayed-Release/omeprazole
- Prilosec is supplied as delayed-release capsules for oral administration. Each delayed-release capsule contains either 10 mg or 20 mg of omeprazole in the form of enteric-coated granules.
(Added: 2-Dec-2002 Hits: 14 Rating: 0 ) Rate It
- Pseudomonas aeruginosa
- Pseudomonas aeruginosa is the epitome of an opportunistic pathogen of humans. The bacterium almost never infects uncompromised tissues, yet there is hardly any tissue that it cannot infect, if the tissue defenses are compromised in some manner.
(Added: 18-Sep-2002 Hits: 12 Rating: 0 ) Rate It
- Pseudomonas aeruginosa
- Pseudomonas aeruginosa is the epitome of an opportunistic pathogen of humans. The bacterium almost never infects uncompromised tissues, yet there is hardly any tissue that it cannot infect, if the tissue defenses are compromised in some manner.
(Added: 18-Sep-2002 Hits: 14 Rating: 0 ) Rate It
- PubMed
- PubMed, a service of the National Library of Medicine, provides access to over 12 million MEDLINE citations back to the mid-1960's and additional life science journals. PubMed includes links to many sites providing full text articles and other related resources.
(Added: 17-Dec-2002 Hits: 19 Rating: 0 ) Rate It
- Singulair As Effective As Inhaled Steroid For Asthma Control
- Results of two studies presented at the 55th annual meeting of the American Academy of Allergy, Asthma and Immunology here this week showed that Merck & Co., Inc.’s once-a-day oral medicine Singulair (montelukast) was similar to an inhaled steroid in its ability to control asthma in adults and was overwhelmingly preferred by children over another leading inhaled asthma control medication studied.
(Added: 23-Oct-2002 Hits: 15 Rating: 0 ) Rate It
- Sporanox and Hepatiits
- In U.S. clinical trials prior to marketing, there have been three cases of reversible idiosyncratic hepatitis reported among more than 2500 patients taking Sporanox (itraconazole capsules). One patient outside the U.S. developed fulminant hepatitis and died during Sporanox administration. Since this patient was on multiple medications, the casual association with Sporanox is uncertain. If clinical signs and symptoms consistent with liver disease develop that may be attributable to itraconazole, Sporanox should be discontinued.
(Added: 2-Dec-2002 Hits: 18 Rating: 0 ) Rate It
- Too Much to Bear
- About the Author
Dr. Gulio Barbero was part of the research team that described Cystic Fibrosis 50 years ago. The late professor emeritus pioneered special diets that helped improve the life expectancy of Cystic Fibrosis patients from just a few years to nearly 31 years today.
(Added: 14-Aug-2002 Hits: 17 Rating: 0 ) Rate It
Prev 20
Next 20
Pages Updated On: 27-Sep-2005 - 04:46:50
Links Engine 2.0 By: Gossamer Threads Inc.
The Cystic Fibrosis-Reaching Out Foundation is a non-profit Foundation under Section 501 (c) 3 of the Internal Revenue Code. Accordingly, the Foundation is not required to pay income taxes. Donors may deduct contributions to the Cystic Fibrosis-Reaching Out Foundation Inc, only to the extent that their contributions are gifts, with no consideration given.
|
